Follow
Zhenhua Xu
Zhenhua Xu
Research Assistant Professor, Children's National Medical Hospital
Verified email at cnmc.org
Title
Cited by
Cited by
Year
Dendrimers as drug carriers: applications in different routes of drug administration
Y Cheng, Z Xu, M Ma, T Xu
Journal of pharmaceutical sciences 97 (1), 123-143, 2008
6092008
Polymer-Coated NaYF4:Yb3+, Er3+ Upconversion Nanoparticles for Charge-Dependent Cellular Imaging
J Jin, YJ Gu, CWY Man, J Cheng, Z Xu, Y Zhang, H Wang, VHY Lee, ...
ACS nano 5 (10), 7838-7847, 2011
3142011
Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study
Y Cheng, H Qu, M Ma, Z Xu, P Xu, Y Fang, T Xu
European journal of medicinal chemistry 42 (7), 1032-1038, 2007
2522007
Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug
M Ma, Y Cheng, Z Xu, P Xu, H Qu, Y Fang, T Xu, L Wen
European journal of medicinal chemistry 42 (1), 93-98, 2007
2432007
MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1∼ let-7d via noncanonical E-box
Z Wang, S Lin, JJ Li, Z Xu, H Yao, X Zhu, D Xie, Z Shen, J Sze, K Li, G Lu, ...
Journal of Biological Chemistry 286 (46), 39703-39714, 2011
972011
miR-216b regulation of c-jun mediated gadd153/chop-dependent apoptosis
Z Xu, Y Bu, N Chinis, C Koumenis, SY Fuchs, JA Diehl
Nature Communications, 2016
762016
New insights into molecules and pathways of cancer metabolism and therapeutic implications
Z Tang, Z Xu, X Zhu, J Zhang
Cancer Communications 41 (1), 16-36, 2021
732021
Upconversion Nanoparticles Conjugated with Gd3+‐DOTA and RGD for Targeted Dual‐Modality Imaging of Brain Tumor Xenografts
J Jin, Z Xu, Y Zhang, YJ Gu, MHW Lam, WT Wong
Advanced healthcare materials 2 (11), 1501-1512, 2013
692013
MYC Drives Group 3 Medulloblastoma through Transformation of Sox2+ Astrocyte Progenitor Cells.
P Ran Tao, Najiba Murad, Zhenhua Xu
Cancer Research 79 (8), 2019
432019
Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma
F Yin, Z Xu, Z Wang, H Yao, Z Shen, F Yu, Y Tang, D Fu, S Lin, G Lu, ...
Biochemical and biophysical research communications 429 (3-4), 168-172, 2012
322012
Transcriptional regulation in model organisms: recent progress and clinical implications
J Tang, Z Xu, L Huang, H Luo, X Zhu
Open Biology 9 (11), 190183, 2019
242019
Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
Z Xu, J Jin, LKS Siu, H Yao, J Sze, H Sun, H Kung, WS Poon, SSM Ng, ...
International journal of pharmaceutics 426 (1-2), 182-192, 2012
222012
Colorimetric determination of polyamidoamine dendrimers and their derivates using a simple and rapid ninhydrin assay
Z Xu, T Xu, Y Cheng, M Ma, P Xu, H Qu, L Wen
Analytical letters 41 (3), 444-455, 2008
122008
Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti2bacterial drugs using sulfamethoxazole (SMZ) as a model drug
M Minglu, C Yiyun, X Zhenhua
European Journal of Medicinal Chemistry 42, 93-98, 2007
122007
Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~ let-7d in glioblastoma
Z Wang, S Lin, J Zhang, Z Xu, Y Xiang, H Yao, L Ge, D Xie, H Kung, G Lu, ...
Oncotarget 7 (35), 56266, 2016
82016
OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma
Z Xu, N Murad, D Malawsky, R Tao, S Rivero-Hinojosa, D Holdhof, ...
Clinical Cancer Research 28 (19), 4278-4291, 2022
72022
The 3′ UTR Variants in the GRP78 Are Not Associated with Overall Survival in Resectable Hepatocellular Carcinoma
X Zhu, F Wang, MCM Lin, L Tian, W Fan, SS Ng, M Liu, J Huang, Z Xu, ...
PLoS One 6 (3), e17783, 2011
42011
Epigenetics in cancer: mechanisms and drug development-volume II
X Zhu, Z Xu, B Li
Frontiers in Genetics 14, 1242960, 2023
12023
Background: MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) play vital regulatory roles in pancreatic cancer (PC) initiation and progression. We aimed to explore the …
Z Xu, D Zhang, Z Zhang, W Luo, R Shi, J Yao, D Li, L Wang, B Liao
Epigenetics in Cancer: Mechanisms and Drug Development, 2022
2022
Epigenetics in Cancer: Mechanisms and Drug Development
H Yuan, Y Huang, S Tao, B Li, Z Xu, Y Qi, B Wu, H Luo, X Zhu
Frontiers in Genetics 13, 831704, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20